Gastrointestinal stromal tumor | Tumor

CURE’s gastrointestinal stromal tumor page features the latest cancer news and updates on gastrointestinal stromal tumors Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in the gastrointestinal stromal tumor.

Grace Helbig, Joaquin Castro Announces Cancer Diagnoses and More

July 7th 2023, 3:00pm

Article

From YouTuber Grace Helbig announcing her cancer diagnosis to the NFL’s Foster Moreau being in full remission, here’s what’s happening in the oncology space this week.

Lining Up New Options for GIST

June 14th 2023, 7:00pm

Article

Patients with GIST have more treatment options than ever, with others currently under development.

Qinlock Becomes Preferred Second-Line Drug for GIST Subset

March 21st 2023, 9:00pm

Article

The National Comprehensive Cancer Network updated their guidelines to state that Qinlock is the recommended second-line treatment for patients with Sutent-intolerant gastrointestinal stromal tumors.

Cancer Helped Me Acknowledge and Appreciate My Dual Identity

March 7th 2023, 2:00pm

Article

As a doctor, I’m used to providing medical care, but once I was diagnosed with cancer, I became a patient — someone receiving medical care, too.

Many Survivors of GISTs, a Rare Cancer, May Experience Cancer-Related Cognitive Impairments After Treatment

October 5th 2022, 3:00pm

Article

Nearly two thirds of patients with GISTs — a rare type of cancer that often begins in the digestive system — indicated that their overall quality of life after treatment had been affected by cancer-related cognitive impairments, also referred to as “chemo brain,” according to analysis of survey data.

GIST Location Predicts Tumor Mutation Profile and Drug Sensitivity

August 13th 2021, 9:00pm

Article

The location of gastrointestinal stromal tumors in the stomach predicts the mutation profile and drug sensitivity, which can provide direction for treatment decisions and selective genomic testing.

Drug-Resistant GIST: Identifying Patients and Finding Solutions

July 14th 2021, 9:00pm

Article

Gastrointestinal stromal tumors that are SDH deficient are less likely to respond to TKI treatment. A researcher discusses the exploration of a new drug that can work in this patient population.

Rare Cancers: Collaboration Moves the Field Forward

July 13th 2021, 3:00pm

Article

Patients, clinicians and researchers should work together to find new therapies for rare cancers, one expert says.

How Do Clinical Trials Work? Cancer Expert Explains It All

July 1st 2021, 3:00pm

Article

Will patients be given a placebo? Are clinical trials safe? An expert answers these questions and more.

When Treatment Options Run Out, Consider a Higher Drug Dose in GIST

June 29th 2021, 1:00pm

Video

In patients with advanced gastrointestinal stromal tumors, a dose escalation of Qinlock after recommended treatment with the agent may be the best next step, answering for the lack of a next approved agent after Qinlock.